Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

RANI

Rani Therapeutics Holdings Inc

Apr 25 • 04:00PM ET

6.56

Dollar change 0.00
Percentage change 0.00	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.33	Insider Own	55.48%	Shs Outstand	26.04M	Perf Week	8.43%
Market Cap	172.53M	Forward P/E	-	EPS next Y	-1.06	Insider Trans	0.63%	Shs Float	11.71M	Perf Month	106.29%
Income	-33.97M	PEG	-	EPS next Q	-0.28	Inst Own	7.65%	Short Float	14.65%	Perf Quarter	79.23%
Sales	0.00M	P/S	-	EPS this Y	19.01%	Inst Trans	6.72%	Short Ratio	13.27	Perf Half Y	228.00%
Book/sh	0.49	P/B	13.28	EPS next Y	1.59%	ROA	-40.94%	Short Interest	1.72M	Perf Year	42.92%
Cash/sh	1.86	P/C	3.52	EPS next 5Y	-9.40%	ROE	-136.64%	52W Range	1.82 - 8.75	Perf YTD	97.59%
Dividend Est.	-	P/FCF	-	EPS past 5Y	0.28%	ROI	-90.95%	52W High	-25.03%	Beta	0.34
Dividend TTM	-	Quick Ratio	6.33	Sales past 5Y	83.82%	Gross Margin	-	52W Low	260.44%	ATR (14)	0.77
Dividend Ex-Date	-	Current Ratio	6.33	EPS Y/Y TTM	-4.04%	Oper. Margin	0.00%	RSI (14)	62.39	Volatility	17.91% 14.43%
Employees	140	Debt/Eq	2.34	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.00	Target Price	9.67
Option/Short	Yes / Yes	LT Debt/Eq	1.90	EPS Q/Q	22.23%	Payout	-	Rel Volume	0.00	Prev Close	6.56
Sales Surprise	-	EPS Surprise	28.95%	Sales Q/Q	-	Earnings	Mar 20 AMC	Avg Volume	129.35K	Price	6.56
SMA20	28.10%	SMA50	59.95%	SMA200	95.81%	Trades		Volume	0	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-17-23	Resumed	BTIG Research	Buy	$24
Oct-11-22	Initiated	UBS	Buy	$15
Jul-27-22	Initiated	H.C. Wainwright	Buy	$22
Jun-13-22	Initiated	Wedbush	Outperform	$28

Mar-21-24 09:45AM	Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:35AM	Q4 2023 Rani Therapeutics Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-20-24 04:05PM	Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update (GlobeNewswire)
Mar-15-24 04:05PM	Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire) +6.25%
Feb-05-24 08:00AM	Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) (GlobeNewswire) +5.73%
08:00AM	Loading…
Dec-14-23 08:00AM	Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist (GlobeNewswire)
Dec-07-23 12:00PM	What Makes Rani Therapeutics Holdings, Inc. (RANI) a New Buy Stock (Zacks)
Nov-08-23 05:53PM	Rani Therapeutics Holdings Inc (RANI) Reports Q3 2023 Financial Results and Corporate Developments (GuruFocus.com)
04:05PM	Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update (GlobeNewswire)
Nov-01-23 04:05PM	Rani Therapeutics Announces Strategic Program Prioritization, Expansion of Manufacturing and Plans to Streamline Business Operations to Support Near-Term Value Drivers and Long-Term Growth of the RaniPill Technology Platform; Reports Preliminary Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-25-23 08:00AM	The RaniPill Capsule, Rani Therapeutics' Oral Delivery Platform, was Well-Tolerated in 60-Day, Repeat-Administration, GLP Safety Study (GlobeNewswire)
Oct-19-23 04:05PM	Rani Therapeutics Announces Successful Oral Delivery of Monoclonal Antibody via High-Capacity Pill in Preclinical Study (GlobeNewswire)
Oct-12-23 04:05PM	Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral Research (GlobeNewswire)
Sep-18-23 08:00AM	Rani Therapeutics Initiates Phase 1 Study of RT-111 (RaniPill® Containing Ustekinumab Biosimilar, CT-P43) (GlobeNewswire)
Sep-07-23 04:05PM	Rani Therapeutics Announces Successful Drug Delivery of High-Capacity Pill in Preclinical Studies (GlobeNewswire)
08:00AM	Loading…
Sep-06-23 08:00AM	Rani Therapeutics to Participate in September Investor Conferences (GlobeNewswire)
Aug-11-23 04:05PM	Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update (GlobeNewswire)
Aug-04-23 04:05PM	Rani Therapeutics to Participate in August Investor Conferences (GlobeNewswire)
Jun-21-23 08:00AM	Rani Therapeutics Presentation On Oral Delivery of PTH for Osteoporosis Named Presidential Poster Competition Winner at ENDO 2023 Annual Conference (GlobeNewswire)
Jun-08-23 08:00AM	Rani Therapeutics Announces Acceptance of Late-Breaking Abstract of Oral Delivery of GLP-1 Agonist at the American Diabetes Association Annual Conference (GlobeNewswire)
Jun-05-23 08:00AM	Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105 (GlobeNewswire)
Jun-01-23 08:00AM	Rani Therapeutics to Present at the Jefferies Healthcare Conference (GlobeNewswire)
May-31-23 08:00AM	Rani Therapeutics Announces Acceptance of Three Abstracts for Presentation at ENDO 2023 Annual Conference (GlobeNewswire)
May-24-23 08:00AM	Rani Therapeutics Appoints Kate McKinley as Chief Business Officer (GlobeNewswire)
May-17-23 09:50AM	2 Strong Buy Penny Stocks With Over 400% Upside on the Horizon (TipRanks) +12.25%
May-10-23 04:05PM	Rani Therapeutics Reports First Quarter 2023 Financial Results; Provides Corporate Update (GlobeNewswire)
Apr-26-23 06:46AM	Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) last week's 14% decline must have disappointed private companies who have a significant stake (Simply Wall St.)
Apr-25-23 08:00AM	Rani Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ (GlobeNewswire)
Apr-11-23 08:00AM	Rani Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-27-23 07:12AM	Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2022 Earnings Call Transcript (Insider Monkey)
04:05PM	Loading…
Mar-22-23 04:05PM	Rani Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Corporate Update (GlobeNewswire)
Mar-16-23 04:05PM	Rani Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates (GlobeNewswire) +5.71%
Jan-09-23 08:30AM	Celltrion and Rani Therapeutics Partner on Development of Oral Monoclonal Antibody Treatment (GlobeNewswire)
Jan-05-23 04:05PM	Rani Therapeutics Receives Feedback from Pre-IND Meeting with FDA; Provides Pipeline Update (GlobeNewswire) +8.12%
Dec-06-22 04:05PM	Rani Therapeutics Announces Repeat-Dose Topline Results from RT-102 Phase 1 Study (GlobeNewswire)
Nov-17-22 05:30AM	Private companies among Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) largest shareholders, saw gain in holdings value after stock jumped 21% last week (Simply Wall St.)
Nov-10-22 05:25PM	Rani Therapeutics Holdings, Inc. (RANI) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Rani Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-09-22 04:05PM	Rani Therapeutics to Present at the Stifel Healthcare Conference (GlobeNewswire)
Oct-28-22 09:55AM	Here's Why Rani Therapeutics Holdings, Inc. (RANI) Is a Great 'Buy the Bottom' Stock Now (Zacks)
Oct-24-22 08:30AM	Rani Therapeutics Announces New RT-111 Development Program and Provides Corporate Update (GlobeNewswire) -10.03%
Sep-27-22 09:06AM	8 Best Stocks to Buy According to Billionaire Marc Lasry (Insider Monkey)
Sep-06-22 04:05PM	Rani Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-11-22 11:47PM	Rani Therapeutics Announces Termination of Public Offering of Class A Common Stock (GlobeNewswire) -25.89%
Aug-10-22 05:45PM	Rani Therapeutics Holdings, Inc. (RANI) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
05:28PM	Rani Therapeutics Announces Proposed Public Offering of Class A Common Stock (GlobeNewswire)
04:28PM	Rani Therapeutics Reports Second Quarter 2022 Financial Results; Provides Corporate Update (GlobeNewswire)
04:23PM	Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of RT-102 in Osteoporosis (GlobeNewswire)
Aug-08-22 08:30AM	Rani Therapeutics Enters into $45 Million Loan Agreement to Support Ongoing RaniPill® Platform Advancement and Clinical Pipeline Development (GlobeNewswire)
Aug-03-22 07:48AM	Investors in Rani Therapeutics Holdings (NASDAQ:RANI) have made a return of 16% over the past year (Simply Wall St.)
May-11-22 04:05PM	Rani Therapeutics Reports First Quarter 2022 Financial Results; Provides Corporate Update (GlobeNewswire)
May-04-22 03:09PM	Companies Like Rani Therapeutics Holdings (NASDAQ:RANI) Are In A Position To Invest In Growth (Simply Wall St.)
May-03-22 04:05PM	Rani Therapeutics to Present at Upcoming Investor Conferences (GlobeNewswire) -6.19%
07:00AM	Rani Therapeutics RaniPill Capsule Named Winner in the Health Category of Fast Companys 2022 World Changing Ideas Awards (GlobeNewswire)
Apr-07-22 04:05PM	Rani Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-29-22 04:05PM	Rani Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results; Provides Corporate Update (GlobeNewswire)
Mar-23-22 08:38PM	Rani Therapeutics to Release Fourth Quarter and Full Year 2021 Financial Results on Tuesday, March 29, 2022 (GlobeNewswire)
08:00AM	Rani Therapeutics Announces Initiation of Phase 1 Study of RT-102 Oral PTH for Osteoporosis (GlobeNewswire)
Feb-23-22 08:00AM	Rani Therapeutics Unveils High-Capacity RaniPill Device For Oral Delivery of Biologics; Reports Preliminary 2021 Consolidated Financial Results (GlobeNewswire) -8.47%
Jan-19-22 04:30AM	5 Biotech Stocks That Are Bucking the Selloff (Barrons.com) +7.97%
Jan-07-22 08:00AM	Rani Therapeutics Appoints Lisa Rometty to Board of Directors (GlobeNewswire)
Dec-20-21 07:26PM	These are the top 10 best performing newly public Bay Area stocks (American City Business Journals)
Nov-15-21 07:31PM	Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Update (GlobeNewswire)
Nov-12-21 04:05PM	Rani Therapeutics Appoints Lyn Baranowski to Board of Directors (GlobeNewswire)
Nov-10-21 04:05PM	Rani Therapeutics to Participate in a Fireside Chat at the Stifel 2021 Virtual Healthcare Conference (GlobeNewswire)
Oct-08-21 12:42PM	Most of this year's flood of new Bay Area public companies are 'under water' (American City Business Journals) +13.29%
Oct-04-21 06:00AM	This Recent Biologics IPO Could Be Heading Toward a Gain of 60% or More (Motley Fool)
Sep-23-21 04:05PM	Rani Therapeutics to Present at Cantor Fitzgerald Virtual Global Healthcare Conference (GlobeNewswire)
Sep-13-21 04:05PM	Rani Therapeutics Reports Second Quarter 2021 Financial Results, Provides Corporate Update (GlobeNewswire) +6.19%
Sep-09-21 08:00AM	Rani Therapeutics Announces Appointment of Eric Groen as General Counsel (GlobeNewswire)
Aug-24-21 02:14PM	Rani Therapeutics, RxSight: 2 Bullish Health Care Stock Picks From BofA (Benzinga)
Aug-13-21 04:05PM	Rani Therapeutics Announces Closing of its Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares (GlobeNewswire) +6.77%
Jul-30-21 08:56AM	Rani Therapeutics Announces Pricing of Initial Public Offering (GlobeNewswire)

Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Imran Talat	Chief Executive Officer	Dec 06 '23	Buy	2.27	10,000	22,700	484,455	Dec 07 05:18 PM
Imran Talat	Chief Executive Officer	Dec 04 '23	Buy	2.57	5,000	12,850	474,455	Dec 06 08:00 AM
Imran Talat	Chief Executive Officer	Nov 29 '23	Buy	2.05	20,000	41,000	469,455	Dec 01 08:00 AM
South Cone Investments Limited	10% Owner	Nov 24 '23	Buy	2.01	5,265,165	10,582,982	12,131,554	Dec 08 04:27 PM
Quiroga Cortes Isidoro Alfonso	10% Owner	Nov 24 '23	Sale	2.01	5,265,165	10,582,982	8,400	Dec 08 04:29 PM
BUTEL JEAN LUC	Director	Nov 17 '23	Buy	2.03	50,500	102,495	50,500	Nov 21 04:05 PM
Nanavaty Maulik	Director	Nov 16 '23	Buy	1.98	500	990	500	Nov 20 08:00 AM
Imran Talat	Chief Executive Officer	Nov 07 '23	Buy	2.00	5,000	9,975	449,455	Nov 09 04:05 PM
South Cone Investments Limited	10% Owner	May 12 '23	Buy	3.98	2,645	10,529	6,866,389	May 15 04:22 PM
South Cone Investments Limited	10% Owner	May 11 '23	Buy	3.87	2,610	10,096	6,863,744	May 15 04:22 PM
South Cone Investments Limited	10% Owner	May 08 '23	Buy	4.46	4,420	19,733	6,861,134	May 10 04:25 PM
South Cone Investments Limited	10% Owner	May 03 '23	Buy	4.81	2,040	9,816	6,856,714	May 05 01:26 PM
South Cone Investments Limited	10% Owner	Apr 28 '23	Buy	4.71	2,173	10,225	6,854,674	May 02 01:09 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RANI

Rani Therapeutics Holdings Inc

Upgrade your FINVIZ experience